Production (Stage)
Cannara Biotech Inc.
LOVFF
$0.9114
$0.00730.81%
OTC PK
| 02/28/2025 | 11/30/2024 | 08/31/2024 | 05/31/2024 | 02/29/2024 | |
|---|---|---|---|---|---|
| Net Income | 9.68M | 4.80M | 4.66M | 3.94M | 4.61M |
| Total Depreciation and Amortization | 4.67M | 4.61M | 4.67M | 4.37M | 4.20M |
| Total Amortization of Deferred Charges | 67.50K | 39.10K | 14.90K | 193.30K | 193.30K |
| Total Other Non-Cash Items | -2.17M | 676.70K | 340.50K | 2.27M | 2.66M |
| Change in Net Operating Assets | -4.29M | 1.67M | -1.56M | -2.79M | -4.99M |
| Cash from Operations | 7.96M | 11.80M | 8.13M | 7.97M | 6.67M |
| Capital Expenditure | -4.53M | -4.34M | -5.49M | -6.46M | -6.10M |
| Sale of Property, Plant, and Equipment | 1.55M | 1.55M | 1.55M | 1.63M | 90.30K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 141.10K | 123.70K | 120.70K | 122.50K | 117.20K |
| Cash from Investing | -2.84M | -2.67M | -3.81M | -4.71M | -5.89M |
| Total Debt Issued | 2.70M | 3.70M | 5.70M | 7.20M | 6.50M |
| Total Debt Repaid | -4.35M | -4.74M | -4.67M | -4.61M | -2.19M |
| Issuance of Common Stock | -- | -- | -- | 0.00 | 0.00 |
| Repurchase of Common Stock | 0.00 | -4.30K | -277.10K | -480.50K | -623.10K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -3.28M | -3.81M | -4.28M | -5.06M | -5.70M |
| Cash from Financing | -3.55M | -3.57M | -2.59M | -2.20M | -1.51M |
| Foreign Exchange rate Adjustments | -- | -- | -- | 0.00 | 500.00 |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.57M | 5.57M | 1.73M | 1.07M | -730.00K |